Psyence Biomedical Ltd
PBM2.850USD
-0.950-25.00%
交易中 （美東）報價延遲15分鐘
853.65K總市值
虧損本益比TTM
關於 Psyence Biomedical Ltd 公司
Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
Psyence Biomedical Ltd簡介
公司代碼PBM
公司名稱Psyence Biomedical Ltd
上市日期Dec 10, 2021
CEOMaresky (Neil)
員工數量12
證券類型Ordinary Share
年結日Dec 10
公司地址121 Richmond Street West Penthouse
城市TORONTO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Canada
郵編M5H 2K1
電話17744604171
網址
公司代碼PBM
上市日期Dec 10, 2021
CEOMaresky (Neil)
Psyence Biomedical Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Marc Balkin
Mr. Marc Balkin
Independent Director
Independent Director
--
--
Dr. Jody Aufrichtig
Dr. Jody Aufrichtig
Chairman of the Board, Strategic Business Development Officer
Chairman of the Board, Strategic Business Development Officer
--
--
Dr. Neil Maresky
Dr. Neil Maresky
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Warwick Corden-Lloyd
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher (Chris) Bull
Mr. Christopher (Chris) Bull
Independent Director
Independent Director
--
--
Dr. Seth Feuerstein
Dr. Seth Feuerstein
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Marc Balkin
Mr. Marc Balkin
Independent Director
Independent Director
--
--
Dr. Jody Aufrichtig
Dr. Jody Aufrichtig
Chairman of the Board, Strategic Business Development Officer
Chairman of the Board, Strategic Business Development Officer
--
--
Dr. Neil Maresky
Dr. Neil Maresky
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Warwick Corden-Lloyd
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher (Chris) Bull
Mr. Christopher (Chris) Bull
Independent Director
Independent Director
--
--
Dr. Seth Feuerstein
Dr. Seth Feuerstein
Independent Director
Independent Director
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 1月2日 週五
更新時間: 1月2日 週五
持股股東
股東類型
持股股東
持股股東
佔比
KAOS Capital Ltd
0.79%
Parallel Advisors, LLC
0.38%
White Lion Capital LLC
0.03%
Virtu Americas LLC
0.03%
AdvisorShares Investments, LLC
0.01%
其他
98.76%
持股股東
持股股東
佔比
KAOS Capital Ltd
0.79%
Parallel Advisors, LLC
0.38%
White Lion Capital LLC
0.03%
Virtu Americas LLC
0.03%
AdvisorShares Investments, LLC
0.01%
其他
98.76%
股東類型
持股股東
佔比
Corporation
0.79%
Investment Advisor
0.41%
Research Firm
0.03%
Venture Capital
0.03%
其他
98.74%
機構持股
更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
32
189.44K
5.32%
-212.62K
2025Q3
38
319.64K
17.07%
+174.04K
2025Q2
45
357.80K
50.17%
+181.11K
2025Q1
45
167.96K
26.60%
+69.68K
2024Q4
82
948.20K
24.27%
+587.08K
2024Q3
88
169.92K
15.90%
-186.51K
2024Q2
92
159.62K
36.84%
-203.47K
2024Q1
96
157.41K
35.61%
-211.56K
2023Q4
88
18.95K
16.18%
-253.66K
2023Q3
87
16.58K
55.18%
-252.44K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
KAOS Capital Ltd
313.88K
16.77%
+313.88K
--
Dec 08, 2025
Parallel Advisors, LLC
151.25K
8.08%
-123.75K
-45.00%
Sep 30, 2025
White Lion Capital LLC
12.55K
0.67%
+12.55K
--
Dec 04, 2024
Virtu Americas LLC
10.32K
0.55%
+10.32K
--
Sep 30, 2025
AdvisorShares Investments, LLC
5.38K
0.29%
+930.00
+20.91%
Sep 30, 2025
Osaic Holdings, Inc.
4.50K
0.24%
+4.50K
--
Sep 30, 2025
BofA Global Research (US)
3.34K
0.18%
--
--
Sep 30, 2025
Stonehage Fleming Financial Services Holdings, Ltd.
561.00
0.03%
--
--
Sep 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
AdvisorShares Psychedelics ETF
0%
AdvisorShares Psychedelics ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
除權除息日
類型
比率
Jan 14, 2026
Merger
6.25→1
May 01, 2025
Merger
7.97→1
Nov 12, 2024
Merger
75→1
Nov 12, 2024
Merger
75→1
Nov 12, 2024
Merger
75→1
Nov 12, 2024
Merger
75→1
公告日期
除權除息日
類型
比率
Jan 14, 2026
Merger
6.25→1
May 01, 2025
Merger
7.97→1
Nov 12, 2024
Merger
75→1
Nov 12, 2024
Merger
75→1
Nov 12, 2024
Merger
75→1
Nov 12, 2024
Merger
75→1
